Literature DB >> 17987921

Leiomyomata uteri: hormonal and molecular determinants of growth.

Richard Enrique Blake1.   

Abstract

OBJECTIVE: To review the available English literature that examines the biology of leiomyoma uteri in African-American women and other ethnic groups. Factors that influence the growth and development of leiomyomas are examined to understand the basis for larger myomas in African-American women.
DESIGN: Literature review of 176 articles regarding the pathobiology of leiomyoma in various ethnic groups.
RESULTS: The initiating factor(s) associated with the transformation of a normal myometrial cell into a leiomyoma cell remain(s) to be determined. Epidemiological studies have confirmed that different ethnic groups develop leiomyomas. However, African-American ethnicity is a risk factor for the development of leiomyomas. Studies have examined diet, genetics, hormonal, growth, enzymatic and molecular determinants of myoma biology, with critical advances in some of these areas. The best radiological tools to identify and monitor leiomyomas are ultrasonography and/or magnetic resonance imaging. Evidence supports progesterone and growth factors (e.g., transforming growth factor-B), have significant impact on the development of leiomyomas.
CONCLUSIONS: Early monitoring and intervention should become standard for African-American women who are at greater risk for developing leiomyomas. There are plausible biological mechanisms that explain the predisposition for developing larger leiomyomas in African-American women as compared with other ethnic groups.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17987921      PMCID: PMC2574407     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  119 in total

1.  Immunohistochemical study of the proliferation index, oestrogen receptors and progesterone receptors A and B in leiomyomata and normal myometrium during the menstrual cycle and under gonadotrophin-releasing hormone agonist therapy.

Authors:  M Nisolle; S Gillerot; F Casanas-Roux; J Squifflet; M Berliere; J Donnez
Journal:  Hum Reprod       Date:  1999-11       Impact factor: 6.918

2.  Transforming growth factor-beta3 is expressed at high levels in leiomyoma where it stimulates fibronectin expression and cell proliferation.

Authors:  A Arici; I Sozen
Journal:  Fertil Steril       Date:  2000-05       Impact factor: 7.329

Review 3.  Advances in uterine leiomyoma research: the progesterone hypothesis.

Authors:  M S Rein
Journal:  Environ Health Perspect       Date:  2000-10       Impact factor: 9.031

4.  Comparing regulation of the connexin43 gene by estrogen in uterine leiomyoma and pregnancy myometrium.

Authors:  J Andersen
Journal:  Environ Health Perspect       Date:  2000-10       Impact factor: 9.031

5.  Inhibitory cross-talk between steroid hormone receptors: differential targeting of estrogen receptor in the repression of its transcriptional activity by agonist- and antagonist-occupied progestin receptors.

Authors:  W L Kraus; K E Weis; B S Katzenellenbogen
Journal:  Mol Cell Biol       Date:  1995-04       Impact factor: 4.272

6.  Transvaginal ultrasonographic findings in the uterus and the endometrium: low prevalence of leiomyoma in a random sample of women age 25-40 years.

Authors:  C Borgfeldt; E Andolf
Journal:  Acta Obstet Gynecol Scand       Date:  2000-03       Impact factor: 3.636

Review 7.  Progesterone: a critical role in the pathogenesis of uterine myomas.

Authors:  M S Rein; R L Barbieri; A J Friedman
Journal:  Am J Obstet Gynecol       Date:  1995-01       Impact factor: 8.661

8.  Estrogen receptor gene expression in human uterine leiomyomata.

Authors:  D D Brandon; T E Erickson; E J Keenan; E Y Strawn; M J Novy; K A Burry; C Warner; G M Clinton
Journal:  J Clin Endocrinol Metab       Date:  1995-06       Impact factor: 5.958

9.  Regression of uterine leiomyomata to the antiprogesterone RU486: dose-response effect.

Authors:  A A Murphy; A J Morales; L M Kettel; S S Yen
Journal:  Fertil Steril       Date:  1995-07       Impact factor: 7.329

10.  Analysis of androgen receptor DNA reveals the independent clonal origins of uterine leiomyomata and the secondary nature of cytogenetic aberrations in the development of leiomyomata.

Authors:  R D Mashal; M L Fejzo; A J Friedman; N Mitchner; R A Nowak; M S Rein; C C Morton; J Sklar
Journal:  Genes Chromosomes Cancer       Date:  1994-09       Impact factor: 5.006

View more
  15 in total

1.  Lower prevalence of non-cavity-distorting uterine fibroids in patients with polycystic ovary syndrome than in those with unexplained infertility.

Authors:  Hao Huang; Hongying Kuang; Fangbai Sun; Michael P Diamond; Richard S Legro; Christos Coutifaris; Ruben Alvero; Randal D Robinson; Peter R Casson; Gregory M Christman; Karl R Hansen; Nanette Santoro; Esther Eisenberg; Heping Zhang
Journal:  Fertil Steril       Date:  2019-03-27       Impact factor: 7.329

2.  Validation of the aging hen (Gallus gallus domesticus) as an animal model for uterine leiomyomas.

Authors:  Sergio A Machado; Janice M Bahr; D Buck Hales; Andrea G Braundmeier; Bradley J Quade; Romana A Nowak
Journal:  Biol Reprod       Date:  2012-10-11       Impact factor: 4.285

3.  Hyperplasia and fibrosis in mice with conditional loss of the TSC2 tumor suppressor in Müllerian duct mesenchyme-derived myometria.

Authors:  Tomoko Kaneko-Tarui; Arno E Commandeur; Amanda L Patterson; Justin L DeKuiper; David Petillo; Aaron K Styer; Jose M Teixeira
Journal:  Mol Hum Reprod       Date:  2014-09-04       Impact factor: 4.025

4.  Gene therapy targeting leiomyoma: adenovirus-mediated delivery of dominant-negative estrogen receptor gene shrinks uterine tumors in Eker rat model.

Authors:  Memy H Hassan; Salama A Salama; Dong Zhang; Hossam M M Arafa; Farid M A Hamada; Hala Fouad; Cheryl C Walker; Ayman Al-Hendy
Journal:  Fertil Steril       Date:  2009-01-14       Impact factor: 7.329

Review 5.  Biomarkers in uterine leiomyoma.

Authors:  Gary Levy; Micah J Hill; Torie C Plowden; William H Catherino; Alicia Y Armstrong
Journal:  Fertil Steril       Date:  2012-11-29       Impact factor: 7.329

6.  Circulating Sex Hormones and Risk of Uterine Fibroids: Study of Women's Health Across the Nation (SWAN).

Authors:  Jason Y Y Wong; Ellen B Gold; Wesley O Johnson; Jennifer S Lee
Journal:  J Clin Endocrinol Metab       Date:  2015-12-15       Impact factor: 5.958

7.  Relaxin increases elastase activity and protease inhibitors in smooth muscle cells from the myometrium compared with cells from leiomyomas.

Authors:  Bertha Chen; Yan Wen; Xiao Yun Yu; Mary Lake Polan
Journal:  Fertil Steril       Date:  2008-06-12       Impact factor: 7.329

8.  Functional gene polymorphism of matrix metalloproteinase-1 is associated with benign hyperplasia of myo- and endometrium in the Russian population.

Authors:  Elena B Morosova; Alexei B Chukhlovin; Natalia V Kulagina; Natalia V Kipich; Areg A Totolian
Journal:  Genet Test Mol Biomarkers       Date:  2012-08-01

Review 9.  Emerging Roles of Long Non-coding RNAs in Uterine Leiomyoma Pathogenesis: a Review.

Authors:  Zahra Falahati; Masoud Mohseni-Dargah; Reza Mirfakhraie
Journal:  Reprod Sci       Date:  2021-04-12       Impact factor: 3.060

10.  The genetic bases of uterine fibroids; a review.

Authors:  Veronica Medikare; Lakshmi Rao Kandukuri; Venkateshwari Ananthapur; Mamata Deenadayal; Pratibha Nallari
Journal:  J Reprod Infertil       Date:  2011-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.